The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

Journal of Experimental Medicine

Volumn 179, Issue 6, 1994, Pages 1895-1902

  Calandra, Thierry ^a   Bernhagen, Jürgen ^a   Mitchell, Robert A ^a   Bucala, Richard ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL SECRETION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HYPOPHYSECTOMY; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA CELL LINE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; T LYMPHOCYTE;

ANIMAL; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; DNA PRIMERS; FEMALE; HUMAN; HYPOPHYSECTOMY; INTRONS; KINETICS; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR;

EID: 0028305693     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.179.6.1895     Document Type: Article

References (33)

1. Wexler, B.C., A.E. Dolgin, and E.W. Tryczynski. 1957. Effects of bacterial polysaccharide (Piromen) on the pituitary-adrenal axis: adrenal ascorbic acid, cholesterol and histologic alterations. Endocrinology. 61:300.
2. Berry, L.J., and D.S. Smythe. 1964. Effects of bacterial endotoxins on metabolism VII. Enzyme induction and cortisone protection. J. Exp. Med. 120:721.
3. Sapolsky, R., C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale. 1987. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science (Wash. DC). 238:522.
4. Silverstein, R., B.R. Turley, C.A. Christoffersen, D.C. Johnson, and D.C. Morrison. 1991. Hydrazine sulfate protects D-galac-tosamine-sensitized mice against endotoxin and tumor necrosis factorJcachectin lethality: evidence of a role for the pituitary. J. Exp Med. 173:357.
5. Bemhagen, J., T. Calandra, R.A. Mitchell, S.B. Martin, KJ. Tracey, W. Voelter, K.R. Manogue, A. Cerami, and R. Bucala. 1993. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (bond). 365:756.
6. Bloom, B.R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (Wash. DC). 153:80.
7. David, J. 1966. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA. 56:72.
8. Nathan, C.F., H.G. Remold, and J.R. David. 1973. Characterization of a lymphocyte factor which alters macrophage function. J. Exp Med. 137:275.
9. Nathan, C.F., M.L. Karnovsky, and J.R. David. 1971. Alterations of macrophage functions by mediators from lymphocytes. J. Exp Med. 133:1356.
10. Churchill, W.H., W.F. Piessens, C.A. Sulis, and J.R. David. 1975. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells.J. Immunol. 115:781.
11. Weiser, WY., P.A. Temple, J.S. Witek-Gianotti, H.G. Remold, S.C. Clark, and J.R. David. 1989. Molecular cloning of cDNA encoding a human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA. 86:7522.
12. Pozzi, L.M., and W.Y. Weiser. 1992. Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells. Cell. Immunol. 145:372.
13. Nathan, C.F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
14. Vadas, M.A., J.R. David, A. Butterworth, N.T. Pisani, and T.A. Siongok. 1979. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J. Immunol. 122:1228.
15. Sherry, B.A., M.A. Vadas, and J.R. David. 1981. Separation of human monocytes and guinea pig macrophages by density gradients of metrizamide. In Methods for Studying Mononuclear Phagocytes. D.D. Adams, P.J. Edelson, and H.S. Koren, editors. Academic Press, New York. 187-193.
16. Gilliland, G., S. Perrin, K. Blanchard, and H.F. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl. Acad. Sci. USA. 87:2275.
17. Elderfield, A.J., J. Newcombe, C. Bolton, and R.J. Flower. 1992. Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosis. J. Neuroimmunol. 39:91.
18. Wolpe, S.D., G. Davatelis, B. Sherry, B. Beutler, D.G. Hesse, H.T. Nguyen, L.L. Moldawer, C.F. Nathan, S.F. Lowry, and A. Cerami. 1988. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp Med. 167:570.
19. Beutler, B., J. Mahoney, N. Le Trang, P. Pskala, and A. Cerami. 1985. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J. Exp Med. 161:984.
20. Beutler, B., I.W. Milsark, and A. Cerami. 1985. CachectinJtumor necrosis factor. Production, distribution and metabolic fate in vivo. J. Immunol. 135:3972.
21. Michie, H.R., K.R. Manogue, D.R. Spriggs, A. Revhaug, S. O’Dwyer, C.A. Dinarello, A. Cerami, S.M. Wolff, and D.W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481.
22. Thurman, G.B., I.A. Braude, P.W. Gray, R.K. Oldham, and H.C. Stevenson. 1985. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody. J. Immunol. 134:305.
23. Herriott, M.J., and R.W. Leu. 1993. Activation of mouse macrophages for migration inhibition and for tumor cytotoxicity is mediated by interferon-gamma priming and triggering by various agents. J. Interferon Res. 7:165.
24. Mclnnes, A., and D.M. Rennick. 1988. Interleukin 4 induces cultured monocytesJmacrophages to form giant multinucleated cells. J. Exp Med. 167:598.
25. Lanahan, A., J.B. Williams, L.K. Sanders, and D. Nathans. 1993. Growth factor-induced delayed early response genes. Mol. Cell. Biol. 12:3919.
26. Wistow, G.J., M.P. Shaughnessy, D.C. Lee, J. Hodin, and P.S. Zelenka. 1993. A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl. Acad. Sci. USA. 90:1272.
27. van Deventer, S.J.H., H.R. Buller, J.W. Ten Cate, A. Sturk, and W. Pauw. 1988. Endotoxemia: an early predictor of septicemia in febrile patients. Lancet. 1:605.
28. Brandtzaeg, P., P. Kierulf, P. Gaustad, A. Skulberg, J. Bruun, S. Halvorsen, and E. Sorensen. 1989. Plasma endotoxin is a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159:195.
29. Danner, R.L., R.J. Elin, J.M. Hosseini, R.A. Wesley, J.M. Reilly, and J.E. Parillo. 1991. Endotoxemia in human septic shock. Chest. 99:169.
30. Tracey, K.J., R Beutler, S.F. Lowry, J. Merryweather, S. Wolpe, I.W. Milsark, R.J. Hariri, T.J. Fahey III, A. Zentella, J.D. Albert, G.T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science (Wash. DC). 234:470.
31. Beutler, B., I.W. Milsark, and A. Cerami. 1985. Passive immunization against cachectinJtumor necrosis factor protects mice from lethal effect of endotoxin. Science (Wash. DC). 229:869.
32. Tracey, K.J., Y. Fong, D.G. Hesse, K.R. Manogue, A.T. Lee, G.C. Kuo, S.F. Lowry, and A. Cerami. 1987. Anti-cachectinJTNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond.). 330:662.
33. Waage, A., T. Espevik, and J. Lamvik. 1986. Detection of tumor necrosis factor-like cytotoxicity in serum from patients with septicemia but not from untreated cancer patients. Scand. J. Immunol. 24:739.